India, April 13 -- The emergency use authorisation granted by India's drugs regulator to Sputnik V, and the government's decision to fast-track similar approvals, conditionally, for any Covid-19 vaccines that have the same in the United States (US), United Kingdom (UK), Europe, and Japan, or which are in the World Health Organization's emergency use listing is welcome. This is a definite step towards increasing access to, and availability of, vaccines - and it is something that the government could have considered a few months ago.

There are more things the government can do to enhance access. Vaccine-making is a complex, expensive, and risky business. One of the few things the Donald Trump administration got right was its decision to pl...